Login to Your Account



WASHINGTON ROUNDUP

Evzio approval part of FDA balancing act on opioid abuse

By Mari Serebrov
Washington Editor

Thursday, April 3, 2014
In the midst of escalating criticism about its approval of Zohydro ER (hydrocodone), the FDA approved Kaleo Inc.’s Evzio (naloxone autoinjector) to rapidly reverse an opioid overdose.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription